Information intended for healthcare professionals only. This formulary decision guide was developed from content supplied by Novo Nordisk in a format developed by Guidelines in Practice. It has been reviewed by Novo Nordisk, who commissioned the development of the formulary decision guide.
If the PDF does not load within 5 seconds, please refresh the page.
UK/SM/0818/0304aDate of preparation: November 2018